The submissions in Canada are for generic forms of semaglutide, the active ingredient in Novo Nordisk's injectable prescription drugs Ozempic and Wegovy, which have been approved by Health Canada for diabetes and weight loss respectively
KLOW BPC-157, TB-500, KPV, and GHK-Cu, typically totaling around 80 mg per vial
The copper complex should be protected from strong reducing agents (ascorbic acid, DTT) which can reduce Cu2+ to Cu+ and destabilize the complex
Until such data exist we must be cautious about assumed synergy
Metabolic health improvements Some individuals experience improved blood sugar stability and insulin sensitivity after switching
At Set Point Medical Weight Loss Clinic, we offer evidence-based treatments, including semaglutide, to support our patients weight loss goals